Xcout Intel
AbelZeta
AbelZeta is a global clinical-stage biopharmaceutical company pioneering T cell-based therapies targeting cancer, inflammation, and immunological issues, with centers in Rockville, Maryland and Shanghai, China.
Subscribe to see AbelZeta’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AbelZeta at a glance
AbelZeta is a biotechnology company headquartered in United States. It has raised at least $120M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $1M in November 2025. Xcout tracks 9 named people at AbelZeta, including Tony (Bizuo) Liu (Chairman and CEO).
AbelZeta leadership
- Tony (Bizuo) LiuChairman and CEO
- Andrew ChanChief Legal Officer
- Yihong YaoChief Scientific Officer
- Jiaqi HuangSenior Vice President, Translational Medicine
- Michael HavertSenior Vice President, Regulatory Affairs
- Hong YiVice President, Technology
3 more named people on record for AbelZeta, with roles, board committees and tenure — see the full roster →
AbelZeta funding rounds
At least $120M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $1M | 6 named | |
| Series A | $120M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get AbelZeta's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AbelZeta in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access